SIGNATUREFD, LLC URGN UROGEN PHARMA LTD

Ownership history in SIGNATUREFD, LLC  ·  18 quarters on record

AI Ownership Summary

SIGNATUREFD, LLC reported UROGEN PHARMA LTD (URGN) in 18 quarterly 13F filings from 2023 Q4 through 2026 Q1. The latest visible filing shows URGN at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this URGN ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SIGNATUREFD, LLC's position in UROGEN PHARMA LTD, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

URGN was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How SIGNATUREFD, LLC held URGN — position size vs. price
% of Fund (quarterly)    URGN price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED 10 0% 0.00% $180 2026-04-07 $18.03
2025 Q4 UNCHANGED 10 0% 0.00% $234 2026-01-20 $19.33
2025 Q3 REDUCED 54.5% +16.9% 10 -12 -54.5% 0.00% $200 2025-10-21 $18.14
2024 Q4 REDUCED 94.2% +3.9% 22 -358 -94.2% 0.00% $234 2025-02-10 $10.73
2024 Q3 REDUCED 23.5% -17.2% 380 -117 -23.5% 0.00% $5K 2024-10-21 $12.52
2024 Q2 REDUCED 23.5% -24.3% 497 -153 -23.5% 0.00% $8K 2024-07-29 $16.13
2024 Q1 ADDED 650 +34 +5.5% 0.00% $10K 2024-05-03 $14.30
2023 Q4 ADDED 616 +536 +670.0% 0.00% $9K 2024-02-01 $15.90
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About SIGNATUREFD, LLC and URGN

These are the practical questions this page is built to answer before you even open the full history table.

How long has SIGNATUREFD, LLC reported owning URGN?

SIGNATUREFD, LLC reported URGN across 8 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported URGN position in SIGNATUREFD, LLC's portfolio?

The largest reported portfolio weight for URGN was 0.00% in 2023 Q4.

What is the latest reported URGN position on this page?

The most recent filing on this page is 2026 Q1, when SIGNATUREFD, LLC reported 10 shares, equal to 0.00% of portfolio, with an estimated market value of $180.

What does the chart on this URGN ownership page compare?

The chart compares SIGNATUREFD, LLC's quarterly URGN portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SIGNATUREFD, LLC time their URGN position?

Based on 13F filing dates vs. subsequent URGN price moves, SIGNATUREFD, LLC correctly timed 9 out of 15 reported position changes (60%). The annualised alpha on URGN relative to SPY over the holding period was -30.1%.

← Back to SIGNATUREFD, LLC Holdings